Non-Coding RNAs in Adrenocortical Cancer: From Pathogenesis to Diagnosis

Decmann, Abel [Decmann, Ábel (Belgyógyászat), author] II. Department of Internal Medicine (SU / FM / C); Perge, Pál [Perge, Pál (endokrinologia), author] II. Department of Internal Medicine (SU / FM / C); Turai, Peter Istvan [Turai, Péter István (belgyógyászat), author] II. Department of Internal Medicine (SU / FM / C); Patócs, Attila [Patócs, Attila Balázs (Orvostudomány), author] National Institute of Oncology; Department of Laboratory Medicine (SU / FM / I); "Lendület" MTA-SE Research Group for Hereditary... (SU / FM / C / IIDIM); Igaz, Peter ✉ [Igaz, Péter (belgyógyászat, en...), author] MTA-SE Molecular Medicine Research Unit (SU / FM / C / DIMO); II. Department of Internal Medicine (SU / FM / C)

English Survey paper (Journal Article) Scientific
Published: CANCERS 2072-6694 12 (2) Paper: 461 , 17 p. 2020
  • SJR Scopus - Oncology: Q1
Identifiers
Subjects:
  • Clinical medicine
Non-coding RNA molecules including microRNAs and long non-coding RNAs (lncRNA) have been implicated in the pathogenesis of several tumors and numerous data support their applicability in diagnosis as well. Despite recent advances, the pathogenesis of adrenocortical cancer still remains elusive and there are no reliable blood-borne markers of adrenocortical malignancy, either. Several findings show the potential applicability of microRNAs as biomarkers of malignancy and prognosis, and there are some data on lncRNA as well. In this review, we present a synopsis on the potential relevance of non-coding RNA molecules in adrenocortical pathogenesis and their applicability in diagnosis from tissue and blood.
Citation styles: IEEEACMAPAChicagoHarvardCSLCopyPrint
2025-04-02 00:10